Chandramohan, Shivani
Salinger, Allison P.
Wendt, Amanda S.
Waid, Jillian L.
Kalam, Md. Abul
Delea, Maryann G.
Comeau, Dawn L.
Sobhan, Shafinaz
Gabrysch, Sabine
Sinharoy, Sheela
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-008977, INV-008977, INV-008977, INV-008977, INV-008977, INV-008977, INV-008977)
United States Agency for International Development (EEM-G-00–04-00013–00, EEM-G-00–04-00013–00, EEM-G-00–04-00013–00, EEM-G-00–04-00013–00, EEM-G-00–04-00013–00, EEM-G-00–04-00013–00, EEM-G-00–04-00013–00)
Bundesministerium für Bildung und Forschung (01ER1201, 01ER1201, 01ER1201, 01ER1201, 01ER1201)
Article History
Received: 29 April 2023
Accepted: 12 November 2023
First Online: 24 November 2023
Declarations
:
: The data analysed in this study were collected in accordance with relevant guidelines and regulations as part of the FAARM trial (ClinicalTrials.gov: NCT02505711). The study protocol was positively reviewed by the ethics committees of the James P Grant School of Public Health at BRAC University in Bangladesh and Heidelberg University in Germany. FAARM is registered with ClinicalTrials.gov (NCT02505711). All study participants gave written informed consent prior to participation in FAARM, and additionally provided verbal informed consent for interviews and FGDs. This analysis used deidentified data.
: Not applicable.
: The authors declare no competing interests.